Annual FCF:
-$4.05B-$230.00M(-6.01%)Summary
- As of today, MRNA annual free cash flow is -$4.05 billion, with the most recent change of -$230.00 million (-6.01%) on December 31, 2024.
- During the last 3 years, MRNA annual free cash flow has fallen by -$17.39 billion (-130.41%).
- MRNA annual free cash flow is now -130.41% below its all-time high of $13.34 billion, reached on December 31, 2021.
Performance
MRNA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$880.00M+$42.00M(+4.56%)Summary
- As of today, MRNA quarterly free cash flow is -$880.00 million, with the most recent change of +$42.00 million (+4.56%) on September 30, 2025.
- Over the past year, MRNA quarterly free cash flow has increased by +$837.00 million (+48.75%).
- MRNA quarterly free cash flow is now -121.82% below its all-time high of $4.03 billion, reached on June 30, 2021.
Performance
MRNA Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$2.66B+$837.00M(+23.91%)Summary
- As of today, MRNA TTM free cash flow is -$2.66 billion, with the most recent change of +$837.00 million (+23.91%) on September 30, 2025.
- Over the past year, MRNA TTM free cash flow has increased by +$1.29 billion (+32.68%).
- MRNA TTM free cash flow is now -119.97% below its all-time high of $13.34 billion, reached on December 31, 2021.
Performance
MRNA TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
MRNA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -6.0% | +48.8% | +32.7% |
| 3Y3 Years | -130.4% | -639.9% | -142.9% |
| 5Y5 Years | -725.9% | -200.8% | -533.8% |
MRNA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -130.4% | at low | -156.1% | +49.4% | -142.9% | +34.3% |
| 5Y | 5-Year | -130.4% | at low | -121.8% | +49.4% | -120.0% | +34.3% |
| All-Time | All-Time | -130.4% | at low | -121.8% | +49.4% | -120.0% | +34.3% |
MRNA Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$880.00M(+4.6%) | -$2.66B(+23.9%) |
| Jun 2025 | - | -$922.00M(+20.8%) | -$3.50B(+13.2%) |
| Mar 2025 | - | -$1.16B(-484.2%) | -$4.03B(+0.5%) |
| Dec 2024 | -$4.05B(-6.0%) | $303.00M(+117.6%) | -$4.05B(-2.5%) |
| Sep 2024 | - | -$1.72B(-17.9%) | -$3.96B(+0.6%) |
| Jun 2024 | - | -$1.46B(-22.9%) | -$3.98B(-8.4%) |
| Mar 2024 | - | -$1.19B(-394.8%) | -$3.67B(+4.0%) |
| Dec 2023 | -$3.83B(-183.5%) | $402.00M(+123.1%) | -$3.83B(-44.0%) |
| Sep 2023 | - | -$1.74B(-51.4%) | -$2.66B(-252.4%) |
| Jun 2023 | - | -$1.15B(+14.1%) | -$754.00M(-223.2%) |
| Mar 2023 | - | -$1.34B(-185.2%) | $612.00M(-86.6%) |
| Dec 2022 | $4.58B(-65.6%) | $1.57B(+863.2%) | $4.58B(-26.1%) |
| Sep 2022 | - | $163.00M(-24.9%) | $6.20B(-32.7%) |
| Jun 2022 | - | $217.00M(-91.8%) | $9.21B(-29.3%) |
| Mar 2022 | - | $2.63B(-17.5%) | $13.03B(-2.3%) |
| Dec 2021 | $13.34B(+580.8%) | $3.19B(+0.4%) | $13.34B(+17.1%) |
| Sep 2021 | - | $3.18B(-21.2%) | $11.39B(+25.4%) |
| Jun 2021 | - | $4.03B(+37.4%) | $9.08B(+81.4%) |
| Mar 2021 | - | $2.94B(+136.6%) | $5.01B(+155.6%) |
| Dec 2020 | $1.96B(+499.0%) | $1.24B(+42.1%) | $1.96B(+219.2%) |
| Sep 2020 | - | $873.46M(+2154.9%) | $613.82M(+264.4%) |
| Jun 2020 | - | -$42.51M(+62.2%) | -$373.44M(+17.0%) |
| Mar 2020 | - | -$112.41M(-7.4%) | -$450.10M(+8.1%) |
| Dec 2019 | -$491.00M(-12.5%) | -$104.71M(+8.0%) | -$489.55M(-0.0%) |
| Sep 2019 | - | -$113.80M(+4.5%) | -$489.50M(-1.2%) |
| Jun 2019 | - | -$119.17M(+21.5%) | -$483.79M(-8.7%) |
| Mar 2019 | - | -$151.86M(-45.1%) | -$445.20M(-2.0%) |
| Dec 2018 | -$436.63M(-12.0%) | -$104.66M(+3.2%) | -$436.63M(+2.3%) |
| Sep 2018 | - | -$108.10M(-34.1%) | -$446.86M(-31.8%) |
| Jun 2018 | - | -$80.58M(+43.8%) | -$339.03M(-30.8%) |
| Mar 2018 | - | -$143.29M(-24.7%) | -$259.12M(-123.0%) |
| Dec 2017 | -$389.88M(-1260.7%) | -$114.89M(>-9900.0%) | -$116.19M(-7521.7%) |
| Sep 2017 | - | -$265.70K(+60.3%) | -$1.52M(-17.7%) |
| Jun 2017 | - | -$668.50K(-83.7%) | -$1.30M(-83.3%) |
| Mar 2017 | - | -$364.00K(-60.9%) | -$706.50K(-35.2%) |
| Dec 2016 | $33.59M(+1619.9%) | - | - |
| Dec 2016 | - | -$226.20K(-518.0%) | -$522.40K(+38.8%) |
| Sep 2016 | - | -$36.60K(+54.1%) | -$854.20K(+35.6%) |
| Jun 2016 | - | -$79.70K(+55.7%) | -$1.33M(+21.2%) |
| Mar 2016 | - | -$179.90K(+67.8%) | -$1.68M(+22.3%) |
| Dec 2015 | -$2.21M(+53.8%) | -$558.00K(-9.8%) | -$2.17M(+28.0%) |
| Sep 2015 | - | -$508.00K(-16.2%) | -$3.01M(+16.7%) |
| Jun 2015 | - | -$437.00K(+34.0%) | -$3.61M(+17.5%) |
| Mar 2015 | - | -$662.00K(+52.8%) | -$4.38M(+8.4%) |
| Dec 2014 | -$4.78M(-1776.8%) | -$1.40M(-26.2%) | -$4.78M(-63.8%) |
| Sep 2014 | - | -$1.11M(+7.5%) | -$2.92M(-85.4%) |
| Jun 2014 | - | -$1.20M(-12.8%) | -$1.57M(-451.9%) |
| Mar 2014 | - | -$1.06M(-331.5%) | -$285.00K(-200.0%) |
| Dec 2013 | $285.00K(+106.5%) | $460.00K(+97.4%) | $285.00K(+133.9%) |
| Sep 2013 | - | $233.00K(+167.8%) | -$840.00K(+36.7%) |
| Jun 2013 | - | $87.00K(+117.6%) | -$1.33M(+22.4%) |
| Mar 2013 | - | -$495.00K(+25.6%) | -$1.71M(+61.1%) |
| Dec 2012 | -$4.39M(+72.8%) | -$665.00K(-162.8%) | -$4.39M(+22.3%) |
| Sep 2012 | - | -$253.00K(+14.2%) | -$5.65M(+44.4%) |
| Jun 2012 | - | -$295.00K(+90.7%) | -$10.16M(+31.3%) |
| Mar 2012 | - | -$3.18M(-65.3%) | -$14.79M(+8.3%) |
| Dec 2011 | -$16.12M(+6.3%) | -$1.92M(+59.7%) | -$16.12M(+5.5%) |
| Sep 2011 | - | -$4.76M(+3.2%) | -$17.05M(+2.8%) |
| Jun 2011 | - | -$4.92M(-9.1%) | -$17.54M(-2.1%) |
| Mar 2011 | - | -$4.51M(-58.1%) | -$17.18M(+0.2%) |
| Dec 2010 | -$17.20M(-125.8%) | -$2.85M(+45.7%) | -$17.20M(+4.9%) |
| Sep 2010 | - | -$5.26M(-15.2%) | -$18.08M(-2.5%) |
| Jun 2010 | - | -$4.56M(-0.6%) | -$17.65M(+8.7%) |
| Mar 2010 | - | -$4.54M(-21.6%) | -$19.34M(-153.8%) |
| Dec 2009 | -$7.62M | -$3.73M(+22.6%) | -$7.62M(+23.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$4.82M(+22.9%) | -$9.97M(+23.2%) |
| Jun 2009 | - | -$6.25M(-187.0%) | -$12.97M(+24.6%) |
| Mar 2009 | - | $7.18M(+218.1%) | -$17.22M(+57.6%) |
| Dec 2008 | -$40.60M(+19.6%) | -$6.08M(+22.3%) | -$40.60M(+18.6%) |
| Sep 2008 | - | -$7.83M(+25.4%) | -$49.84M(+9.1%) |
| Jun 2008 | - | -$10.49M(+35.2%) | -$54.81M(+2.0%) |
| Mar 2008 | - | -$16.20M(-5.7%) | -$55.90M(-10.8%) |
| Dec 2007 | -$50.47M(-102.3%) | -$15.33M(-19.8%) | -$50.47M(-14.9%) |
| Sep 2007 | - | -$12.79M(-10.4%) | -$43.91M(-6.0%) |
| Jun 2007 | - | -$11.59M(-7.6%) | -$41.41M(-34.7%) |
| Mar 2007 | - | -$10.77M(-22.8%) | -$30.74M(-23.2%) |
| Dec 2006 | -$24.95M(+31.2%) | -$8.77M(+14.8%) | -$24.95M(-0.4%) |
| Sep 2006 | - | -$10.29M(-1025.9%) | -$24.85M(+4.3%) |
| Jun 2006 | - | -$914.00K(+81.7%) | -$25.96M(+22.7%) |
| Mar 2006 | - | -$4.98M(+42.5%) | -$33.58M(+7.4%) |
| Dec 2005 | -$36.24M(-69.9%) | -$8.67M(+23.9%) | -$36.24M(-35.3%) |
| Sep 2005 | - | -$11.40M(-33.5%) | -$26.79M(-20.1%) |
| Jun 2005 | - | -$8.54M(-11.6%) | -$22.30M(-9.5%) |
| Mar 2005 | - | -$7.65M(-1072.9%) | -$20.37M(+4.5%) |
| Dec 2004 | -$21.33M(-115.1%) | $786.00K(+111.4%) | -$21.33M(+26.7%) |
| Sep 2004 | - | -$6.91M(-4.6%) | -$29.11M(-1.5%) |
| Jun 2004 | - | -$6.60M(+23.3%) | -$28.67M(-7.1%) |
| Mar 2004 | - | -$8.61M(-23.1%) | -$26.77M(-170.0%) |
| Dec 2003 | -$9.91M(-11.8%) | -$7.00M(-8.1%) | -$9.91M(-16.6%) |
| Sep 2003 | - | -$6.47M(-37.5%) | -$8.50M(-58.9%) |
| Jun 2003 | - | -$4.70M(-157.0%) | -$5.35M(-2601.5%) |
| Mar 2003 | - | $8.25M(+247.8%) | -$198.00K(+97.8%) |
| Dec 2002 | -$8.87M(-18.0%) | -$5.58M(-68.4%) | -$8.87M(-37.1%) |
| Sep 2002 | - | -$3.31M(-841.6%) | -$6.47M(-61.9%) |
| Jun 2002 | - | $447.00K(+207.2%) | -$4.00M(+37.1%) |
| Mar 2002 | - | -$417.00K(+86.9%) | -$6.35M(+15.5%) |
| Dec 2001 | -$7.51M(+11.2%) | -$3.18M(-276.9%) | -$7.51M(-25.7%) |
| Sep 2001 | - | -$844.00K(+55.7%) | -$5.97M(+14.6%) |
| Jun 2001 | - | -$1.91M(-20.6%) | -$7.00M(-14.4%) |
| Mar 2001 | - | -$1.58M(+3.8%) | -$6.12M(+27.6%) |
| Dec 2000 | -$8.46M(-1.9%) | -$1.64M(+12.0%) | -$8.46M(+14.7%) |
| Sep 2000 | - | -$1.87M(-82.5%) | -$9.91M(+2.3%) |
| Jun 2000 | - | -$1.02M(+73.9%) | -$10.14M(+7.1%) |
| Mar 2000 | - | -$3.92M(-26.4%) | -$10.92M(-31.5%) |
| Dec 1999 | -$8.30M(-159.4%) | -$3.10M(-47.6%) | -$8.30M(-38.3%) |
| Sep 1999 | - | -$2.10M(-16.7%) | -$6.00M(-46.3%) |
| Jun 1999 | - | -$1.80M(-38.5%) | -$4.10M(-46.4%) |
| Mar 1999 | - | -$1.30M(-62.5%) | -$2.80M(+12.5%) |
| Dec 1998 | -$3.20M(+15.8%) | -$800.00K(-300.0%) | -$3.20M(+3.0%) |
| Sep 1998 | - | -$200.00K(+60.0%) | -$3.30M(+23.3%) |
| Jun 1998 | - | -$500.00K(+70.6%) | -$4.30M(+10.4%) |
| Mar 1998 | - | -$1.70M(-88.9%) | -$4.80M(-26.3%) |
| Dec 1997 | -$3.80M(-442.9%) | -$900.00K(+25.0%) | -$3.80M(-31.0%) |
| Sep 1997 | - | -$1.20M(-20.0%) | -$2.90M(-26.1%) |
| Jun 1997 | - | -$1.00M(-42.9%) | -$2.30M(-130.0%) |
| Mar 1997 | - | -$700.00K(-16.7%) | -$1.00M(-66.7%) |
| Dec 1996 | -$700.00K(>-9900.0%) | - | - |
| Sep 1996 | - | -$600.00K(-300.0%) | -$600.00K(>-9900.0%) |
| Jun 1996 | $0.00(0.0%) | $300.00K(+400.0%) | $0.00(+100.0%) |
| Mar 1996 | - | -$100.00K(+50.0%) | -$300.00K(-50.0%) |
| Dec 1995 | - | -$200.00K(>-9900.0%) | -$200.00K(>-9900.0%) |
| Sep 1995 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 1995 | $0.00(-100.0%) | $0.00(0.0%) | $100.00K(0.0%) |
| Mar 1995 | - | $0.00(0.0%) | $100.00K(+200.0%) |
| Dec 1994 | - | $0.00(-100.0%) | -$100.00K(-200.0%) |
| Sep 1994 | - | $100.00K(>+9900.0%) | $100.00K(0.0%) |
| Jun 1994 | $100.00K | $0.00(+100.0%) | $100.00K(0.0%) |
| Mar 1994 | - | -$200.00K(-200.0%) | $100.00K(-66.7%) |
| Dec 1993 | - | $200.00K(+100.0%) | $300.00K(+200.0%) |
| Sep 1993 | - | $100.00K | $100.00K |
FAQ
- What is Moderna, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Moderna, Inc.?
- What is Moderna, Inc. annual free cash flow year-on-year change?
- What is Moderna, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Moderna, Inc.?
- What is Moderna, Inc. quarterly free cash flow year-on-year change?
- What is Moderna, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Moderna, Inc.?
- What is Moderna, Inc. TTM free cash flow year-on-year change?
What is Moderna, Inc. annual free cash flow?
The current annual free cash flow of MRNA is -$4.05B
What is the all-time high annual free cash flow for Moderna, Inc.?
Moderna, Inc. all-time high annual free cash flow is $13.34B
What is Moderna, Inc. annual free cash flow year-on-year change?
Over the past year, MRNA annual free cash flow has changed by -$230.00M (-6.01%)
What is Moderna, Inc. quarterly free cash flow?
The current quarterly free cash flow of MRNA is -$880.00M
What is the all-time high quarterly free cash flow for Moderna, Inc.?
Moderna, Inc. all-time high quarterly free cash flow is $4.03B
What is Moderna, Inc. quarterly free cash flow year-on-year change?
Over the past year, MRNA quarterly free cash flow has changed by +$837.00M (+48.75%)
What is Moderna, Inc. TTM free cash flow?
The current TTM free cash flow of MRNA is -$2.66B
What is the all-time high TTM free cash flow for Moderna, Inc.?
Moderna, Inc. all-time high TTM free cash flow is $13.34B
What is Moderna, Inc. TTM free cash flow year-on-year change?
Over the past year, MRNA TTM free cash flow has changed by +$1.29B (+32.68%)